| CAD cases | CAD controls | P |
---|---|---|---|
N = 711 | N = 638 |  | |
Age (years) | 66.64 ± 7.84 | 66.37 ± 7.82 | 0.531 |
Telomere length (T/S ratio) | 1.00 ± 0.23 | 1.02 ± 0.24 | 0.100 |
Plasma fatty acid (% of total) | |||
 n-3 fatty acid (%) | 2.63 (2.04, 3.69) | 2.83 (2.11, 4.02) | 0.013 |
 18:3 (n-3) ALA (%) | 0.28 (0.21, 0.38) | 0.28 (0.22, 0.38) | 0.310 |
 20:5 (n-3) EPA (%) | 0.39 (0.31, 0.49) | 0.42 (0.32, 0.53) | 0.002 |
 22:6 (n-3) DHA (%) | 1.92 (1.38, 2.79) | 2.02 (1.45, 3.05) | 0.020 |
 n-6 fatty acid (%) | 45.07 ± 4.68 | 45.43 ± 4.81 | 0.165 |
 18:2(n-6) LA (%) | 36.14 ± 4.63 | 36.43 ± 4.68 | 0.252 |
 18:3(n-6) GLA (%) | 0.19 (0.13, 0.29) | 0.19 (0.13, 0.29) | 0.824 |
 20:3(n-6) DGLA (%) | 0.88 (0.67, 1.13) | 0.87 (0.69, 1.10) | 0.652 |
 20:4(n-6) AA (%) | 7.57 ± 1.68 | 7.67 ± 1.79 | 0.328 |
 n6:n3 ratio | 17.02 (11.98, 22.10) | 16.14 (10.93, 21.62) | 0.053 |
 Gender (%male) | 459 (64.56%) | 401 (62.85%) | 0.516 |
rs529143 | Â | Â | 0.759 |
 AA | 522 (75.98%) | 461 (74.47%) |  |
 AC | 155 (22.56%) | 150 (24.23%) |  |
 CC | 10 (1.46%) | 8 (1.29%) |  |
 MAF | 0.127 | 0.134 |  |